.webp)
Key takeaways:
- Throughout 2025, Nerva collaborated with research teams at Mayo Clinic, Massachusetts General Hospital, Mount Sinai, Monash University, and an NHS Trust to advance brain-gut therapy evidence.
- The round-up summarizes published, presented, and ongoing studies spanning IBS, IBD in remission, upper-GI functional disorders, pelvic pain conditions, and mechanisms of change.
- The report highlights how DGBI care is evolving and where digital brain-gut tools can be referred in everyday clinical workflows.
- Clinicians interested in partnering on future studies or learning more about the research program can contact the Nerva team at healthcare@nervahealth.com.
Explore emerging insights across IBS, IBD in remission, upper-GI functional disorders, pelvic pain conditions, and mechanisms of change
Read Nerva's 2025 Research Round-Up
Throughout 2025, we collaborated with leading research teams to advance evidence in brain-gut therapy and DGBI management. Our partners included:
Mayo Clinic
Massachusetts General Hospital
Mount Sinai
Monash University
NHS Trust
This report provides concise summaries of our published, presented, and ongoing studies, highlighting how DGBI care is evolving and where digital brain-gut tools can be referred in everyday clinical workflows.
Let's collaborate
Nerva’s mission is grounded in rigorous research and thoughtful clinical collaboration. If you're interested in partnering on future studies or learning more about our research program, we'd love to connect.
Get in touch with us at healthcare@nervahealth.com
